CS logo
small CS logo
University of Milano Bicocca

Monza, Italy
Università statale a Milano

About University of Milano Bicocca


L'Università degli Studi di Milano-Bicocca è un'università statale italiana fondata nel 1998.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Milano Bicocca
5
Ariad Pharmaceuticals
1
Erasmus Medical Center
1
Fondazione Don Carlo Gnocchi Onlus
1
Incyte Biosciences International Sàrl
1
Total Rows: 5

Clinical Trials at University of Milano Bicocca


During the past decade, University of Milano Bicocca conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122221100110000Started TrialsCompleted Trails20192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)
2010-09-30
2019-01-17
Completed
449
International Guillain-Barré Syndrome Outcome Study
2012-05-01
2024-09-01
Active, not recruiting
2,000
Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).
2009-03-01
2013-09-01
Completed
94
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
2020-01-29
2025-01-04
Recruiting
60
HD-tDCS to Enhance Cognitive Training in Multiple Sclerosis
2019-11-21
2024-12-01
Suspended
44
ERAS Versus ERAS Plus Artificial Nutrition in Open Pancreatoduodenectomy
2022-04-14
2022-12-31
Recruiting
240
The Salivary Raman COVID-19 Fingerprint
2020-06-01
2022-12-31
Recruiting
120
Italian Validation of the Pelvic Floor Distress Inventory (PFDI-20) Questionnaire
2021-10-01
2022-04-30
Completed
200

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Milano Bicocca" #1 sponsor was "University of Milano Bicocca" with 5 trials, followed by "Ariad Pharmaceuticals" with 1 trials sponsored, "Erasmus Medical Center" with 1 trials sponsored, "Fondazione Don Carlo Gnocchi Onlus" with 1 trials sponsored and "Incyte Biosciences International Sàrl" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Milano Bicocca" #1 collaborator was "Agenzia Italiana del Farmaco" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Milano Bicocca: 5University of Milano Bicocca: 5Ariad Pharmaceuticals: 1Ariad Pharmaceuticals: 1Erasmus Medical Center: 1Erasmus Medical Center: 1Fondazione Don CarloGnocchi Onlus: 1Fondazione Don CarloGnocchi Onlus: 1Incyte BiosciencesInternational Sàrl: 1Incyte BiosciencesInternational Sàrl: 1

Created with Highcharts 11.1.0Top CollaboratorsAgenzia Italiana del Farmaco: 1Agenzia Italiana del Farmaco: 1

Clinical Trials Conditions at University of Milano Bicocca


According to Clinical.Site data, the most researched conditions in "University of Milano Bicocca" are "Accelerated Phase Chronic Myeloid Leukemia" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Lymphocytic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Blast Phase Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "University of Milano Bicocca" in a lesser frequency.

Clinical Trials Intervention Types at University of Milano Bicocca


Most popular intervention types in "University of Milano Bicocca" are "Drug" (3 trials), "Other" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ponatinib" (2 trials), "Hydroxychloroquine + Prednisone" (1 trials), "Prednisone" (1 trials), "Raman analysis of saliva, characterization of the Raman database and building of the classification model" (1 trials) and "Real HD-tDCS + CCT" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University of Milano Bicocca


The vast majority of trials in "University of Milano Bicocca" are 7 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at University of Milano Bicocca


Currently, there are NaN active trials in "University of Milano Bicocca". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Milano Bicocca, 1 suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Milano Bicocca, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2Phase 1: 1Phase 1: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 4Recruiting: 4Completed: 3Completed: 3Active, not recruiting: 1Active, not recruiting: 1Suspended: 1Suspended: 1